SGLT-2 INHIBITORS AND GUT MICROBIOTA SGLT-2is are prescribed to treat T2DM but are also considered first line therapy for heart failure and CKD [27]
Ozempic was first approved in 2017 to treat type 2 diabetes, and Wegovy was approved to treat obesity in 2021
Both methods have shown prominent weight loss results, documented in clinical studies
Alcohol use disorders before and after bariatric surgery: a systematic review and meta-analysis
How long does it take for probiotics to help with semaglutide side effects
The result is a solution containing: Low-molecular-weight peptide fragments (85% of the composition) that can cross the blood-brain barrier Free amino acids (15%) including glutamate, glycine, and serine Neurotrophic factors mimicking BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) The key mechanism: Cerebrolysin upregulates neuroplasticity, protects neurons from excitotoxicity, supports synaptic remodeling, and promotes the growth and repair of neural pathways
